Repligen RGEN 深 沪
等待开盘 09-23 09:30:00 美东时间
186.75
+6.040
+3.34%
华盛通- 最 高188.20
- 今 开180.72
- 成交量 115.98万股
- 最 低 180.00
- 昨 收 180.71
- 总市值 105.39亿
- 52周最高 188.73
- 市盈率 静 216.05
- 换手率 2.06%
- 52周最低 100.99
- 委 比 -83.61%
- 总股本 5643.56万
- 历史最高 327.32
- 量 比 1.15
- 振 幅 4.54%
- 历史最低 2.90
- 每 手 1
- 风险率 20.21%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TE Connectivity declares $0.78 dividend
TE Connectivity (TEL) declares $0.78/share quarterly dividend, in line with previous. Forward yield 1.54% Payable Dec. 11; for shareholders of record Nov. 20; ex-div Nov. 20. See TEL Dividend Scorecar...
09-17 04:47
Are BLFS, FTHM, AUUD, VRME Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
09-12 01:06
美股大行评级 | 戴尔、Adobe获大行上调目标价；甲骨文绩前目标价遭调低
今日重点评级关注：富国银行：维持Pyxis Oncology"超配"评级，目标价从12美元升至19美元；Oppenheimer：维持Opus Genetics"跑赢大市"评级，目标价从10美元升至20美元
09-10 15:00
BioLife Solutions Nears Completion of Repligen Acquisition
BioLife Solutions ( ($BLFS) ) just unveiled an announcement. On July 21, 2026, ...
09-10 06:19
UBS Maintains Buy on Repligen, Raises Price Target to $225
UBS analyst Dan Leonard maintains Repligen (NASDAQ:RGEN) with a Buy and raises the price target from $195 to $225.
09-10 01:56
Repligen clears antitrust hurdle in BioLife Solutions acquisition
Repligen ( ($RGEN) ) just unveiled an update. On July 21, 2026, Repligen entere...
09-09 06:10
BioLife Solutions Sets October Vote on Cash‑and‑Stock Merger With Repligen
New activity is brewing for BioLife Solutions ( ($BLFS) ). The company has subm...
09-05 05:57
William Blair updates its stock Conviction List
William Blair added BJ’s Restaurants (BJRI), Aehr Test Systems (AEHR), MP Materials (MP), APi Group (APG), BrightSpring Health Services (BTSG), Curtiss-Wright (CW), James Hardie Industries (JHX) and U...
09-01 19:59
Repligen Corporation to Present at Wells Fargo 21st Annual Healthcare Conference
Repligen Corporation will participate in the Wells Fargo 21st Annual Healthcare Conference in Boston on September 9th. CEO Olivier Loeillot and CFO Jason Garland will join an analyst-led discussion at 1:30 p.m. ET. A live webcast and replay will be available on Repligen’s Investor Relations website.
08-26 11:30
BioLife Details Strategic Repligen Merger Communication to Staff
BioLife Solutions ( ($BLFS) ) has provided an update. On July 21, 2026, BioLife...
08-04 06:21
